404839003: Ibandronate sodium (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Calcium regulating agent (substance)\Bone resorption inhibitor (substance)\Bisphosphonate (substance)\Ibandronate\Ibandronate sodium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Phosphorus and/or phosphorus compound (substance)\Phosphorus compound\Organic phosphorus compound\Bisphosphonate (substance)\Ibandronate\Ibandronate sodium (substance)

\Organic compound\Organic phosphorus compound\Bisphosphonate (substance)\Ibandronate\Ibandronate sodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2148669014 Ibandronate sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2156718018 Ibandronate sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

816981000172117 ibandronate sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ibandronate sodium (substance)	Is a	Ibandronate	true	Inferred relationship	Some
Ibandronate sodium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Ibandronic acid (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing ibandronate sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some
Ibandronate sodium 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some
Ibandronate sodium 1mg/mL injection solution 3mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some
Ibandronate sodium 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some	1
Ibandronate sodium 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ibandronate sodium (substance)	Inferred relationship	Some	1
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ibandronate sodium (substance)	Inferred relationship	Some	1
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ibandronate sodium (substance)	Inferred relationship	Some	1
Ibandronate sodium monohydrate	Is a	False	Ibandronate sodium (substance)	Inferred relationship	Some
Ibandronate sodium 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ibandronate sodium (substance)	Inferred relationship	Some	1
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ibandronate sodium (substance)	Inferred relationship	Some	1
Ibandronate sodium monohydrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Ibandronate sodium (substance)	Inferred relationship	Some
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ibandronate sodium (substance)	Inferred relationship	Some	1
Product containing precisely ibandronic acid (as ibandronate sodium) 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ibandronate sodium (substance)	Inferred relationship	Some	1
Product containing precisely ibandronic acid (as ibandronate sodium) 150 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ibandronate sodium (substance)	Inferred relationship	Some	1

Reference Sets